EndeavorOTC: Outplay ADHD 2.2.1

Start your free trial today and unlock your Focus Score. EndeavorOTC is an evidence-based treatment for ADHD that is designed to improve symptoms of attention and focus. It offers a game-based approach that can be accessed anytime and anywhere.

EndeavorOTC now features a unique attention metric called Focus Score. This personalized metric has been validated against clinical study data, allowing users to track meaningful improvements in their focus. The predicted user outcomes based on increasing this metric have also been verified.

EndeavorOTC is specifically tailored for adults aged 18 and older who are experiencing challenges related to inattention, which can significantly impact their quality of life. These challenges may include diminished focus, difficulty completing tasks or projects, and trouble keeping track of important items. Available through subscription, EndeavorOTC does not require a prescription.

The effectiveness of EndeavorOTC has been tested in a clinical trial involving over 220 participants over a 6-week period. The results showed that 83% of the participants demonstrated clinical improvement in their ability to focus, while 73% reported improvements in their quality of life. These improvements included better project management, timely completion of tasks, and improved organization skills such as keeping track of essential items like phones, wallets, and keys. No lasting or severe side effects were observed during any of the clinical trials for EndeavorOTC (1,2).

EndeavorOTC works by challenging users to tap targets and navigate obstacles in order to enhance attention and focus. The game continuously measures performance and uses adaptive algorithms to adjust difficulty levels, providing a personalized treatment experience.

Playing EndeavorOTC can easily fit into your daily routine. The more you play, the better your results will be. By playing the game every day for an initial six-week period, you can expect to see improvements in your attention and other aspects that contribute to your ability to focus. Clinical trial data informs the target Focus Score increase for this six-week timeframe, which is directly associated with improvements in ADHD-related symptoms and overall quality of life. In fact, for the majority of individuals, there is still room for further improvement in both Focus Score and cognitive abilities, as well as better management of ADHD symptoms beyond the initial six-week course of treatment.

It is important to note that EndeavorOTC is made available under the current Enforcement Policy for Digital Health Devices for Treating Psychiatric Disorders during the COVID-19 Public Health Emergency issued by the U.S. Food and Drug Administration (FDA). However, it has not been specifically cleared or authorized by the FDA for its indications.

Prior to starting EndeavorOTC treatment or making any medical decisions, it is recommended that patients consult their healthcare provider.

© 2023 Akili Interactive Labs, Inc. All Rights Reserved. Akili, EndeavorRx, Endeavor, Akili Care, ADHD Insight, Insight, EndeavorRx Insight, EndeavorOTC, SSME, and Akili Assist, as well as the logos for each, are trademarks or registered trademarks of Akili Interactive Labs, Inc. Other trademarks are the property of their respective owners.

For full indication language, please visit https://www.endeavorotc.com/IFU/.

For more information, visit https://www.endeavorotc.com/.

Contact [email protected] for any questions.

Terms of Use: https://my.akili.care/terms

Privacy Notice: https://www.akiliinteractive.com/privacy-notice

1 As measured by improvement on the TOVA® ACS. Internal data on file.

2 As measured by the validated Adult ADHD Quality of Life Scale (AAQoL). Internal data on file.